Prestige Brand Holdings Inc (PBH) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Prestige Brand Holdings Inc stock $79.96, price $42.98, upside +86.0%, quality 64 out of 100. Rating: strongly undervalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range $42.98 – $89.09 · fair‑value band $54.58 – $105.13 · the $42.98 price screens below the $79.96 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Prestige Brand Holdings in your weekly email
Every Wednesday you see whether Prestige Brand Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Show moreShow less
It operates in two segments, North American OTC Healthcare and International OTC Healthcare.
The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name.
It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand.
It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018.
Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Stock analysis
Prestige Brand Holdings Inc (PBH) currently trades at $42.98, while our model-based Fair Value estimate is $79.96, implying the stock looks roughly 46% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $80.75 per share, and 17 of the 22 models we run sit above the $42.98 price.
Bear case: the Earnings-Based group reads lowest at $33.63, and 5 of the 22 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $54.58 (bear) to $105.13 (bull), the price of $42.98 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Prestige Brand Holdings Inc reported revenue of $1.1B in FY2026 versus $1.1B in FY2022, a compound +0.0%/yr. Reported net income was $190M in FY2026, compounding −1.9%/yr from FY2022.
Key figures
Market cap $2.1B Mid · P/E ratio 12.0 · P/S ratio 1.90 · EPS (TTM) $3.57 · Net margin 15.6% · Return on equity 9.1% · Return on assets (EBIT) 7.5% (5-year average) · Operating margin 20.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 57 out of 100 (low confidence).
What moves the price
The share trades about 39% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 86%, PBH screens cheaper than that median.
Fair Value models
Bear$54.58Fair Value $79.96Bull$105.13
Price $42.98 · Upside +86.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then ($2.17 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, one officer or director sold shares worth $18,350 and none bought.
SaleJeffrey ZerilloSenior VP Operations6× since Nov 28, 2025: 4,209 shares, avg. $58.53$246,374May 11, 2026
SaleJohn E ByomDirector3,000 shares at $59.35$178,050Nov 25, 2025
Plus 5 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.63/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−4.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.9%
Start year 2021 (pandemic). Over 10 years: +3.0% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.3%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+3.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3.7% vs 10.1%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.32% → 28%
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+8.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −5.0% a year for the price and +5.6% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (96 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
AI conclusion: Recurring revenue from established over-the-counter brands supports stability in a defensive niche, while elevated leverage constrains financial flexibility.
Main risk: Ongoing pressure from generic rivals risks eroding the recurring cash flows generated by the established product portfolio.
Prestige Consumer Healthcare generates recurring revenue from established over-the-counter brands in a defensive healthcare niche. The company is due to report second-quarter results this week after earlier sales softness. Will those numbers confirm steady cash flows from its product portfolio or expose ongoing pressure from generic rivals?
Compare Prestige Brand Holdings Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 549 stocks
Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside+86.0% · Top 25%
Profitability
Return on equity (12 months)9.1% · Above median
Return on assets5.4% · Above median
Net margin (12 months)15.6% · Top 25%
Operating margin (12 months)20.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)6.5% · Above median
Balance sheet
Debt / equity0.53× · Highest 25%
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/E (12 months)12.0× · Cheapest 25%
P/B1.11× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Prestige Brand Holdings Inc (PBH) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $79.96 versus a price of $42.98, about +86% upside (undervalued).
What is the fair value of PBH?
Our model-based fair value for Prestige Brand Holdings Inc is $79.96 (as of Nov 6, 2026), built from audited fundamentals. The current price: $42.98.
What is the quality score of PBH?
Prestige Brand Holdings Inc has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Prestige Brand Holdings Inc (PBH)?
Our model-based price target is the fair value of $79.96 (as of Nov 6, 2026) from 22 valuation models. Cautious scenario $54.58, optimistic scenario $105.13. It is a calculation from audited fundamentals, not an analyst target.
What is the Prestige Brand Holdings Inc stock forecast for 2026?
Our models put fair value at $79.96, about +86% upside versus a price of $42.98 (undervalued). Cautious scenario $54.58, optimistic scenario $105.13. The calculation is refreshed regularly with new filings.
What is the revenue of Prestige Brand Holdings Inc (PBH)?
Prestige Brand Holdings Inc reported trailing-twelve-month revenue of about $1.1B (latest available figure, as of Nov 6, 2026).
What growth is priced into Prestige Brand Holdings Inc (PBH)?
For today's price to be fair in a discounted-cash-flow model, Prestige Brand Holdings Inc would have to grow free cash flow by -2.8 % per year for five years (discount rate 8.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.9 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of PBH use?
Our models discount Prestige Brand Holdings Inc at 8.5 %: a base by market capitalisation (mid), damped by beta 0.30, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Prestige Brand Holdings Inc that is -2.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.5 %) and the same formula as our fair value.
How much growth has Prestige Brand Holdings Inc (PBH) delivered so far?
Over the past 5 years revenue at Prestige Brand Holdings Inc grew +2.9 % a year. The price currently implies free-cash-flow growth of -2.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Prestige Brand Holdings Inc (PBH) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Prestige Brand Holdings Inc (-2.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Prestige Brand Holdings Inc (PBH)?
The free-cash-flow yield on the price is 12.14 %: that much free cash flow Prestige Brand Holdings Inc produces per unit of market value. When it exceeds the discount rate of our models (8.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Prestige Brand Holdings Inc (PBH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Prestige Brand Holdings Inc it is $79.96 per share (as of Nov 6, 2026), against a price of $42.98. It is the blended result of 22 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Prestige Brand Holdings Inc stock overvalued or undervalued in 2026?
As of Nov 6, 2026, PBH trades below its calculated fair value: price $42.98, fair value $79.96, a gap of about +86% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PBH?
No. The price is what the market pays today ($42.98); the fair value is what the company's own numbers justify ($79.96). For Prestige Brand Holdings Inc the two are $36.98 per share apart. That gap is exactly why we show both numbers side by side.
How much is Prestige Brand Holdings Inc worth?
The market values Prestige Brand Holdings Inc at about $2.1B (market capitalisation, as of Nov 6, 2026). Per share that is $42.98; our models calculate a fair value of $79.96 per share.
What do the bullish and bearish scenarios say about PBH?
Our models span a range for Prestige Brand Holdings Inc: cautious scenario $54.58, base $79.96, optimistic $105.13 per share (as of Nov 6, 2026, price $42.98). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PBH?
Prestige Brand Holdings Inc trades at a price-to-earnings ratio of 12.0 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $79.96 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings, 5 of the years ex one-offs: 14.4. Other multiples: PEG 1.4, P/B 1.1, P/S 1.9, EV/EBITDA 9.3.
What is the PEG ratio of PBH?
The PEG ratio of Prestige Brand Holdings Inc is 1.44 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Prestige Brand Holdings Inc (PBH)?
Balance-sheet figures for Prestige Brand Holdings Inc (as of Nov 6, 2026): return on equity 9.1%, debt of 0.53 per unit of equity. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is PBH from its 52-week high?
Prestige Brand Holdings Inc trades at $42.98, about 39% below its 52-week high of $70.21 and at the low of $42.98 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $79.96 is for.
Which stocks are comparable to Prestige Brand Holdings Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Prestige Brand Holdings Inc stock attractive at the current price?
The data as of Nov 6, 2026: price $42.98, calculated fair value $79.96 (+86%), Quality Score 64/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PBH calculated?
We run Prestige Brand Holdings Inc through 22 models from 6 families: DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $79.96 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Prestige Brand Holdings Inc currently trades 46% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Prestige Brand Holdings Inc (PBH)?
The closing price on Nov 6, 2026 was $42.98. Our model-based fair value is $79.96, about +86% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Prestige Brand Holdings Inc right now?
The price is below even our cautious bear case ($54.58). The market is more pessimistic than our downside scenario. Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($54.58 to $105.13) leaves room in how you read the outcome.
Where does the earnings growth of Prestige Brand Holdings Inc (PBH) come from?
Earnings per share at Prestige Brand Holdings Inc grew +11.4 % a year from 2015 to 2026. Broken into its drivers: revenue per share +4.5 %, EBIT margin +0.6 %, tax rate +2.0 %, residual (interest, one-offs) +3.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Prestige Brand Holdings Inc
How large is the market capitalisation of Prestige Brand Holdings Inc (PBH)?
The market capitalisation of Prestige Brand Holdings Inc is $2.1B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Prestige Brand Holdings Inc (PBH)?
The price-to-sales ratio of Prestige Brand Holdings Inc is 1.90 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Prestige Brand Holdings Inc (PBH)?
Earnings per share at Prestige Brand Holdings Inc are $3.57 (price ÷ EPS = P/E 12.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Prestige Brand Holdings Inc (PBH)?
The net margin of Prestige Brand Holdings Inc is 15.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Prestige Brand Holdings Inc (PBH)?
The return on equity (ROE) of Prestige Brand Holdings Inc is 9.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Prestige Brand Holdings Inc (PBH)?
On an EBIT basis the return on assets of Prestige Brand Holdings Inc is 7.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Prestige Brand Holdings Inc (PBH)?
The operating margin of Prestige Brand Holdings Inc is 20.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Prestige Brand Holdings Inc (PBH)?
Revenue at Prestige Brand Holdings Inc is growing +6.5% versus a year earlier (3y avg −1.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Prestige Brand Holdings Inc (PBH)?
Earnings per share at Prestige Brand Holdings Inc are growing −35.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Prestige Brand Holdings Inc (PBH) carry?
The net debt of Prestige Brand Holdings Inc is $982M (fiscal year 2026, ≈ 3.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Prestige Brand Holdings Inc in the live analysis
One click puts Prestige Brand Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 6, 2026